Literature DB >> 26452639

Motion Sickness: Current Knowledge and Recent Advance.

Li-Li Zhang1, Jun-Qin Wang2, Rui-Rui Qi2, Lei-Lei Pan2, Min Li2, Yi-Ling Cai2.   

Abstract

Motion sickness (MS) is a common physiological response to real or virtual motion. Numerous studies have investigated the neurobiological mechanism and the control measures of MS. This review summarizes the current knowledge about pathogenesis and pathophysiology, prediction, evaluation, and countermeasures of MS. The sensory conflict hypothesis is the most widely accepted theory for MS. Both the hippocampus and vestibular cortex might play a role in forming internal model. The pathophysiology focuses on the visceral afference, thermoregulation and MS-related neuroendocrine. Single-nucleotide polymorphisms (SNPs) in some genes and epigenetic modulation might contribute to MS susceptibility and habituation. Questionnaires, heart rate variability (HRV) and electrogastrogram (EGG) are useful for diagnosing and evaluating MS. We also list MS medications to guide clinical practice. Repeated real motion exposure and combined visual-vestibular interaction training accelerate the progress of habituation. Behavioral and dietary countermeasures, as well as physiotherapy, are also effective in alleviating MS symptoms.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  Countermeasure; Evaluation; Motion sickness; Pathogenesis; Prediction

Mesh:

Year:  2015        PMID: 26452639      PMCID: PMC6492910          DOI: 10.1111/cns.12468

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  22 in total

Review 1.  The Neurophysiology and Treatment of Motion Sickness.

Authors:  Andreas Koch; Ingolf Cascorbi; Martin Westhofen; Manuel Dafotakis; Sebastian Klapa; Johann Peter Kuhtz-Buschbeck
Journal:  Dtsch Arztebl Int       Date:  2018-10-12       Impact factor: 5.594

2.  Benign course of episodic dizziness disorders in childhood.

Authors:  Doreen Huppert; Thyra Langhagen; Thomas Brandt
Journal:  J Neurol       Date:  2017-03-07       Impact factor: 4.849

3.  Prevalence of motion sickness in various vestibular disorders: a study on 749 patients.

Authors:  Michael Strupp; Thomas Brandt; Doreen Huppert; Eva Grill
Journal:  J Neurol       Date:  2018-07-07       Impact factor: 4.849

4.  Assessment of Sea Sickness in Naval Personnel: Incidence and Management.

Authors:  Arvind K Gupta; B Vijaya Kumar; Renu Rajguru; K D Parate
Journal:  Indian J Occup Environ Med       Date:  2021-07-09

Review 5.  Antihistamines for motion sickness.

Authors:  Nadine Karrim; Ryan Byrne; Nombulelo Magula; Yougan Saman
Journal:  Cochrane Database Syst Rev       Date:  2022-10-17

6.  Symptom Presentation After Concussion and Pre-existing Anxiety Among Youth Athletes.

Authors:  Matthew Kent; Anna Brilliant; Kirk Erickson; William Meehan; David Howell
Journal:  Int J Sports Med       Date:  2020-06-03       Impact factor: 2.997

Review 7.  Functional Neuroanatomy for Posture and Gait Control.

Authors:  Kaoru Takakusaki
Journal:  J Mov Disord       Date:  2017-01-18

8.  Sex and Age Differences in Motion Sickness in Rats: The Correlation with Blood Hormone Responses and Neuronal Activation in the Vestibular and Autonomic Nuclei.

Authors:  Wei Zhou; Junqin Wang; Leilei Pan; Ruirui Qi; Peng Liu; Jiluo Liu; Yiling Cai
Journal:  Front Aging Neurosci       Date:  2017-02-15       Impact factor: 5.750

9.  Phencynonate S-isomer as a eutomer is a novel central anticholinergic drug for anti-motion sickness.

Authors:  Pingxiang Xu; Ying Liu; Liyun Wang; Yi Wu; Xuelin Zhou; Junhai Xiao; Jianquan Zheng; Ming Xue
Journal:  Sci Rep       Date:  2019-02-13       Impact factor: 4.379

10.  Effects of head motion on postural stability in healthy young adults with chronic motion sensitivity.

Authors:  Abdulaziz A Albalwi; Eric G Johnson; Ahmad A Alharbi; Noha S Daher; Tim K Cordett; Oluwaseun I Ambode; Fahad H Alshehri
Journal:  Arch Physiother       Date:  2020-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.